[基因疗法治疗HIV感染]。

IF 0.7 4区 医学 Q4 VIROLOGY
Virologie Pub Date : 2023-10-01 DOI:10.1684/vir.2023.1021
Ryan P Goguen, Michelle J Chen, Owen R S Dunkley, Anne Gatignol, Robert J Scarborough
{"title":"[基因疗法治疗HIV感染]。","authors":"Ryan P Goguen, Michelle J Chen, Owen R S Dunkley, Anne Gatignol, Robert J Scarborough","doi":"10.1684/vir.2023.1021","DOIUrl":null,"url":null,"abstract":"<p><p>To date, the only intervention that has cured HIV infection has been bone marrow transplants from HIV-resistant donors to HIV-infected recipients. This approach has been used to both cure hematological malignancies and HIV infection, but it cannot be widely adopted due to the high risk of mortality associated with cell transplants between individuals. To overcome this limitation, several approaches have been developed to generate HIV resistance using gene therapy in an infected individual's own cells. With the growing arsenal of effective methods to generate HIV-resistant cells, a safe and effective combination gene therapy approach to cure HIV infection is fast approaching. Here, we review several gene therapy-based methods to generate HIV-resistant cells including the expression of antiviral genes, genome editing, and transcriptional gene silencing. Their varied mechanisms, advantages, and disadvantages are discussed, and perspectives are provided for how they may be combined to design an effective gene therapy for HIV.</p>","PeriodicalId":49377,"journal":{"name":"Virologie","volume":null,"pages":null},"PeriodicalIF":0.7000,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"[Gene therapy to cure HIV infection].\",\"authors\":\"Ryan P Goguen, Michelle J Chen, Owen R S Dunkley, Anne Gatignol, Robert J Scarborough\",\"doi\":\"10.1684/vir.2023.1021\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>To date, the only intervention that has cured HIV infection has been bone marrow transplants from HIV-resistant donors to HIV-infected recipients. This approach has been used to both cure hematological malignancies and HIV infection, but it cannot be widely adopted due to the high risk of mortality associated with cell transplants between individuals. To overcome this limitation, several approaches have been developed to generate HIV resistance using gene therapy in an infected individual's own cells. With the growing arsenal of effective methods to generate HIV-resistant cells, a safe and effective combination gene therapy approach to cure HIV infection is fast approaching. Here, we review several gene therapy-based methods to generate HIV-resistant cells including the expression of antiviral genes, genome editing, and transcriptional gene silencing. Their varied mechanisms, advantages, and disadvantages are discussed, and perspectives are provided for how they may be combined to design an effective gene therapy for HIV.</p>\",\"PeriodicalId\":49377,\"journal\":{\"name\":\"Virologie\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.7000,\"publicationDate\":\"2023-10-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Virologie\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1684/vir.2023.1021\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"VIROLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Virologie","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1684/vir.2023.1021","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"VIROLOGY","Score":null,"Total":0}
引用次数: 0

摘要

迄今为止,治愈艾滋病毒感染的唯一干预措施是从抗艾滋病毒的供体向感染艾滋病毒的受者进行骨髓移植。这种方法已被用于治疗血液恶性肿瘤和HIV感染,但由于个体间细胞移植相关的高死亡率,它不能被广泛采用。为了克服这一限制,已经开发了几种方法,通过在受感染个体自身细胞中使用基因治疗来产生HIV抗性。随着产生抗HIV细胞的有效方法越来越多,一种安全有效的联合基因治疗方法正在迅速接近。在这里,我们回顾了几种基于基因治疗的方法来产生hiv抗性细胞,包括抗病毒基因的表达,基因组编辑和转录基因沉默。讨论了它们的不同机制、优点和缺点,并就如何将它们结合起来设计有效的HIV基因治疗提供了观点。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
[Gene therapy to cure HIV infection].

To date, the only intervention that has cured HIV infection has been bone marrow transplants from HIV-resistant donors to HIV-infected recipients. This approach has been used to both cure hematological malignancies and HIV infection, but it cannot be widely adopted due to the high risk of mortality associated with cell transplants between individuals. To overcome this limitation, several approaches have been developed to generate HIV resistance using gene therapy in an infected individual's own cells. With the growing arsenal of effective methods to generate HIV-resistant cells, a safe and effective combination gene therapy approach to cure HIV infection is fast approaching. Here, we review several gene therapy-based methods to generate HIV-resistant cells including the expression of antiviral genes, genome editing, and transcriptional gene silencing. Their varied mechanisms, advantages, and disadvantages are discussed, and perspectives are provided for how they may be combined to design an effective gene therapy for HIV.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Virologie
Virologie VIROLOGY-
CiteScore
1.20
自引率
22.20%
发文量
31
审稿时长
>12 weeks
期刊介绍: Virologie offers top-level information for all those for whom virology is already the main or an important part of their activity: biologists, clinicians, pharmacists, veterinarians, agronomists, etc.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信